AI in Rare Disease Diagnostics Market Size, Share and Trends Analysis 2026 to 2035
Segmentation of AI in Rare Disease Diagnostics Market :
AI in Rare Disease Diagnostics Market by Component
- Hardware
- Software
- Services
AI in Rare Disease Diagnostics Market by Deployment Mode
- Cloud-based
- On-premise
AI in Rare Disease Diagnostics Market by Technology
- Computer Vision
- Machine Learning
- Natural Language Processing
- Deep Learning
- Others
AI in Rare Disease Diagnostics Market by Application
- Metabolic Disorders
- Genetic Disorders
- Oncology Disorders
- Neurological Disorders
- Others
AI in Rare Disease Diagnostics Market by End-user
- Hospitals
- Research Institutes
- Diagnostic Centers
- Others
AI in Rare Disease Diagnostics Market-By Region
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global `Snapshot
Chapter 4. Global AI in Rare Disease Diagnostics MarketVariables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2035
4.8. Global AI in Rare Disease Diagnostics MarketPenetration & Growth Prospect Mapping (US$ Mn), 2025-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/impact of AI on AI IN RARE DISEASE DIAGNOSTICS MARKETIndustry Trends
Chapter 5. AI in Rare Disease Diagnostics MarketSegmentation 1: By Type of Component, Estimates & Trend Analysis
5.1. Market Share By Type of Component, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Component:
5.2.1. Software
5.2.2. Hardware
5.2.3. Services
Chapter 6. AI in Rare Disease Diagnostics MarketSegmentation 2: By Type of Deployment Mode, Estimates & Trend Analysis
6.1. Market Share By Type of Deployment Mode, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Deployment Mode:
6.2.1. Cloud-Based and On-Premises
Chapter 7. AI in Rare Disease Diagnostics MarketSegmentation 3: By Type of Technology, Estimates & Trend Analysis
7.1. Market Share By Type of Technology, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Technology:
7.2.1. Machine Learning
7.2.2. Deep Learning
7.2.3. Natural Language Processing
7.2.4. Computer Vision
7.2.5. Others
Chapter 8. AI in Rare Disease Diagnostics MarketSegmentation 4: By Application Area, Estimates & Trend Analysis
8.1. Market Share By Application Area, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Applicaion Area:
8.2.1. Genetic Disorders
8.2.2. Metabolic Disorders
8.2.3. Neurological Disorders
8.2.4. Oncology Disorders
8.2.5. Others
Chapter 9. AI in Rare Disease Diagnostics MarketSegmentation 5: By Type of End User, Estimates & Trend Analysis
9.1. Market Share By End User, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of End User:
9.2.1. Hospitals
9.2.2. Diagonastic Center
9.2.3. Research Institutes
9.2.4. Others
Chapter 10. AI in Rare Disease Diagnostics MarketSegmentation 6: Regional Estimates & Trend Analysis
10.1. Global AI in Rare Disease Diagnostics Market, Regional Snapshot 2025 & 2035
10.2. North America
10.2.1. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.2.3. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.2.4. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.2.5. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.2.6. North America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035
10.3. Europe
10.3.1. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.3.3. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.3.4. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.3.5. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.3.6. Europe AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035
10.4. Asia Pacific
10.4.1. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.4.3. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.4.4. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.4.5. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.4.6. Asia Pacific AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035
10.5. Latin America
10.5.1. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.5.3. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.5.4. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.5.5. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.5.6. Latin America AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035
10.6. Middle East & Africa
10.6.1. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts by country, 2022-2035
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Component, 2022-2035
10.6.3. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
10.6.4. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Deployment Mode, 2022-2035
10.6.5. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of Application Area, 2022-2035
10.6.6. Middle East & Africa AI in Rare Disease Diagnostics MarketRevenue (US$ Million) Estimates and Forecasts By Type of End User, 2022-2035
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Bayer (Germany)
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. BioMind (China)
11.2.3. Congenica (UK)
11.2.4. Deep Genomics (Canada)
11.2.5. Enlitic (US)
11.2.6. Face2Gene (US)
11.2.7. Fabric Genomics (US)
11.2.8. FDNA (US)
11.2.9. Freenome (US)
11.2.10. GeneDx (US)
11.2.11. IBM Watson Health (US)
11.2.12. Invitae (US)
11.2.13. Mendel.ai (US)
11.2.14. Nostos Genomics (Germany)
11.2.15. PathAI (US)
11.2.16. PhenoTips (Canada)
11.2.17. Raremark (UK)
11.2.18. SOPHiA GENETICS (Switzerland)
11.2.19. Tempus Labs (US
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AI in Rare Disease Diagnostics Market Size is valued at USD 1.7 Bn in 2025 and is predicted to reach USD 19.4 Bn by the year 2035
AI in Rare Disease Diagnostics Market is expected to grow at a 28.7% CAGR during the forecast period for 2025 to 2034.
Deep Genomics, Bayer, Congenica, Enlitic, Face2Gene, BioMind, Fabric Genomics, FDNA, IBM Watson Health, Invitae, Freenome, GeneDx, Mendel.ai, Nostos Genomics, PathAI, SOPHiA GENETICS, Tempus Labs, PhenoTips, and Raremark
Component, Deployment Mode, Technology, Application and End-user are the key segments of the AI in Rare Disease Diagnostics Market.
North America region is leading the AI in Rare Disease Diagnostics Market.